Clinical investigations have demonstrated the dysregulation of multiple inflammatory mediators in various forms of PAH, such as IL-1, IL-6, TGF-β, and CCR2 (Figure 2) [12,18,70,71]. This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.